Then, we basically demonstrated that cinaciguat inhibited the PLCβ1 activation to attenuate the intracellular Ca2+ overload-ER stress pathway and protected the osteoblasts from diabetes. The gene discussed is PLCB1; the disease is diabetes mellitus.